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Abstract
In Australia the PVL - positive ST93-IV [2B], colloquially known as ‘‘Queensland CA-MRSA’’ has become the dominant CA-
MRSA clone. First described in the early 2000s, ST93-IV [2B] is associated with skin and severe invasive infections including
necrotizing pneumonia. A singleton by multilocus sequence typing (MLST) eBURST analysis ST93 is distinct from other S
aureus clones. To determine if the increased prevalence of ST93-IV [2B] is due to the widespread transmission of a single
strain of ST93-IV [2B] the genetic relatedness of 58 S. aureus ST93 isolated throughout Australia over an extended period
were studied in detail using a variety of molecular methods including pulsed-field gel electrophoresis, spa typing, MLST,
microarray DNA, SCCmec typing and dru typing. Identification of the phage harbouring the lukS-PV/lukF-PV Panton
Valentine leucocidin genes, detection of allelic variations in lukS-PV/lukF-PV, and quantification of LukF-PV expression was
also performed. Although ST93-IV [2B] is known to have an apparent enhanced clinical virulence, the isolates harboured few
known virulence determinants. All PVL-positive isolates carried the PVL-encoding phage WSa2USA and the lukS-PV/lukF-PV
genes had the same R variant SNP profile. The isolates produced similar expression levels of LukF-PV. Although multiple
rearrangements of the spa sequence have occurred, the core genome in ST93 is very stable. The emergence of ST93-MRSA is
due to independent acquisitions of different dru-defined type IV and type V SCCmec elements in several spa-defined ST93-
MSSA backgrounds. Rearrangement of the spa sequence in ST93-MRSA has subsequently occurred in some of these strains.
Although multiple ST93-MRSA strains were characterised, little genetic diversity was identified for most isolates, with PVL-
positive ST93-IVa [2B]-t202-dt10 predominant across Australia. Whether ST93-IVa [2B] t202-dt10 arose from one PVL-positive
ST93-MSSA-t202, or by independent acquisitions of SCCmec-IVa [2B]-dt10 into multiple PVL-positive ST93-MSSA-t202 strains
is not known.
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The community-associated methicillin resistant Staphylococcus
aureus (CA-MRSA) worldwide epidemic is polyclonal, however
several well characterized clones predominate in different regions
of the world: Sequence type (ST) 8-IV [2B] (USA300) and ST1-IV
[2B] (USA400) in North America [1,2]; ST80-IV [2B] (European
clone) in Europe [3], North Africa [4] and the Middle East [5];
ST59-V [5C2&5] (Taiwan clone) in Taiwan [6], ST30-IV [2B]
(South West Pacific [SWP] CA-MRSA) in the Western Pacific
[7,8] and ST772-MRSA-V [5C2] (Bengal Bay clone) in India and
Bangladesh [9]. Transmission of these clones into other regions
has occurred [10,11]. The occurrence of concurrent epidemics of
CA-MRSA in many countries by different clones has been striking.
Equally noteworthy are a number of common features of these
epidemics, prominent among them the ability to cause severe
infections in young otherwise healthy people and the carriage of
lukS-PV/lukF-PV Panton Valentine Leukocidin (PVL) encoding
genes by the organism.
In Australia the PVL - positive ST93-IV [2B], colloquially
known as ‘‘Queensland CA-MRSA’’, has recently emerged to
become the dominant CA-MRSA clone. First described in the
early 2000s, ST93 is a singleton by MLST eBURST analysis and
is therefore distinct from other S aureus clones [12].
In the 2010 Australian Group for Antimicrobial Resistance
(AGAR) Community S aureus Surveillance Programme (SAP10)
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ST93-IV [2B] accounted for 41.4% of all CA-MRSA, 27.6% of all
MRSA and 4.9% of all S aureus community-onset infections
(http://www.agargroup.org/files/FED%20REPORT%20SAP
210%20MRSA%20FINAL%20shrink.pdf.). The mean age of
patients with ST93-IV [2B] infections (31 years, median
25 years) was significantly lower (P,0.0001) than the mean
age of patients with PVL negative CA-MRSA infections
(53 years; median 57 years).
ST93-IV [2B] is associated with skin infection and severe
invasive infection including necrotizing pneumonia, deep-seated
abscess, osteomyelitis, septic arthritis and septicaemia [13,14,15].
Although ST93-IV [2B] has an apparent enhanced clinical
virulence, the recently sequenced ST93-IV [2B] strain
‘‘JKD6159’’ has a relative paucity of recognizable virulence
determinants [16,17]. This strain however does contain genes
encoding three important CA-MRSA virulence factors, Hla, PVL
and a-type phenol soluble modulins (PSMs), and when compared
to three other well-characterised Australian MRSA strains, ST1-
IV [2B], ST30-IV [2B] and ST239-III [3B] and the epidemic
North American strain, USA300, was shown to be the most
virulent in two in vivo models [17].
While predominately an Australian strain, ST93-IV [2B] has
been reported in New Zealand, accounting for 5.1% of all MRSA
referred to the Institute of Environmental Science and Research in
2010 (http://www.surv.esr.cri.nz/PDF_surveillance/Antimicrobial/
MRSA/aMRSA_2010.pdf), and in the United Kingdom, [18], where
many cases have epidemiological links to Australia.
In Western Australia (WA) ST93-IV [2B] was first identified in
2003 [19] and in SAP10 accounted for 28.8% of the state’s CA-
MRSA community-onset infections. In the mid 1990s S aureus
screening of indigenous people living in WA remote communities
demonstrated the most prevalent methicillin susceptible S aureus
(MSSA) linage isolated was the PVL-positive ST93 MSSA clone
[20]. Although seven CA-MRSA clones from genetically diverse
backgrounds were identified in these communities, no ST93
MRSA was found during this time.
As Australia is a geographically large country with the majority
of the population densely concentrated in a few major cities which
are separated in many instances by vast desert areas, it is to be
expected that different CA-MRSA clones will have evolved in
different areas of Australia. To better understand the molecular
epidemiology of ST93-IV [2B], the aim of this study was to
analyse the genetic relatedness of S. aureus ST93 isolated
throughout Australia over an extended period and to determine
if the increased prevalence of ST93-IV [2B] has been due to the
widespread transmission of a single strain of ST93-IV [2B] or has
been due to multiple independent acquisitions of the SCCmec
element into different strains of ST93 MSSA.
Materials and Methods
Bacterial Strains and Identification
Overall 58 ST93 S. aureus were included in the study. The 13
ST93-MSSA included four isolates from remote aboriginal
communities in WA, isolated from 1995 to 2003; two isolates
from the Northern Territory, isolated in 1992; five isolates from
WA, isolated in 2008; and single isolates from Victoria, isolated in
2007, and Queensland, isolated in 2008. The 45 ST93-MRSA
included 30 isolates from across Australia from the 2000 to 2008
AGAR Community onset S. aureus programs, and 15 isolates from
WA from 2003 to 2009. S. aureus species and methicillin resistance
was confirmed by the detection of nuc (thermostable extracellular
nuclease) and mecA (methicillin resistance) genes by PCR as
previously described [21].
Susceptibility Testing
An antibiogram was performed by disk diffusion on Mueller-
Hinton agar according to the Clinical and Laboratory Standards
Institute (CLSI) recommendations [22]. A panel of eight
antimicrobial drugs was tested: erythromycin (15 mg), tetracycline
(30 mg), trimethoprim (5 mg), ciprofloxacin (5 mg), gentamicin
(10 mg), rifampin (5 mg), fusidic acid (10 mg), and mupirocin
(5 mg). CLSI interpretive criteria [23] were used for all drugs
except fusidic acid [24] and mupirocin [25].
PFG
Electrophoresis of chromosomal DNA was performed as
previously described [26], using a contour-clamped homogeneous
electric field (CHEF) DR III system (Bio-Rad Laboratories Pty
Ltd). Chromosomal patterns were examined visually, scanned with
a Quantity One device (Bio-Rad Laboratories Pty Ltd), and
digitally analyzed using FPQuest (Bio-Rad Laboratories Pty Ltd).
S. aureus strain NCTC 8325 was used as a reference strain.
MLST and Spa Typing
Chromosomal DNA for MLST and spa typing was prepared
using a DNeasy tissue kit (Qiagen Pty Ltd).
MLST was performed as previously described [27]. The
sequences were submitted to http://www.mlst.net/where an
allelic profile was generated and an ST assigned.
spa typing, a DNA sequenced-based analysis of the protein A
gene variable region was performed as previously described [28]
using the nomenclature as described on the Ridom website
(http://spa.ridom.de/). Cluster analysis of spa sequences was
performed using the spa typing plug-in tool of the BioNumerics
software program (version 6.6; Applied Maths, Ghent, Belgium).
The analysis compares and aligns sequences via an algorithm
based on potential tandem spa repeat duplications, substitutions,
and indels (the DSI model) [29]. A minimum spanning tree (MST)
was generated from the similarity matrix with the root node
assigned to the sequence type with the greatest number of related
types. The default software parameters were used for analysis with
a bin distance of 1.0%. Thus, the distance between spa types of
99% to 100% similarity was 0, 98% to 99% similarity was assigned
a distance of 1, etc., on the MST. For cluster analysis, only spa
types separated by an MST distance of #1 (i.e., if they were
$98% similar) were considered closely related and assigned to the
same cluster.
DNA Microarray
Arrays and reagents were obtained from Alere Technologies,
Jena Germany. The principle of the assay, related procedures, and
a list of targets has been described previously [30,31]. Target genes
included species markers, markers for accessory gene regulator
(agr) alleles and capsule types, virulence factors, resistance genes,
staphylococcal superantigen-like/exotoxin-like genes (set/ssl genes)
and genes encoding adhesion proteins and immune evasion
factors. Probes for mecA, ugpQ, xylR, kdp, ccr’s, mecI and two probes
for mecR were used for SCCmec typing.
SCCmec Typing
The strategy used for SCCmec typing was as previously
described [32]. SCCmec nomenclature is used as proposed by
the International Working Group on the Classification of
Staphylococcal Cassette Chromosome Elements (IWG-SCC)
[33]. Briefly, the structural type is indicated by a Roman numeral,
with a lowercase letter indicating the subtype, and the ccr complex
and the mec complex are indicated by an Arabic numeral and an
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uppercase letter respectively in parenthesis. Where there is an
extra ccr element, this is indicated by ‘‘&’’ and an Arabic numeral
designating the ccr type. When there is an extra ccr element present
whose precise location is unknown it is indicated by an ‘‘&’’ and ccr
number outside the parentheses.
PVL
PCR for the detection of PVL determinants was performed as
previously described [34].
PVL Phage Identification
PCRs were performed to detect the six PVL-encoding phages
(WSa2MW, WSa2958, WPVL, W108PVL, WSLT and WSA2USA)
as previously described [35,36].
Detection of Allelic Variations in Luks-PV/lukF-PV Genes
Detection of single nucleotide polymorphisms (SNPs) in a
defined region of the lukS-PV/lukF-PV genes were performed as
previously described [36,37]. Sequences obtained were compared
to the proposed progenitor PVL gene in WSLT/ST30.
Quantification of In vitro LukF-PV Expression
PVL is a 2-component exotoxin and both LukS-PV and LukF-
PV are required for activity. LukF-PV was measured instead of
LukS-PV to obtain an anti-LukF-PV antibody with increased
specificity of binding as there was more sequence divergence
between lukF-PV and the orthologous 2-component S. aureus
exotoxins compared to lukS-PV. To produce recombinant LukF-
PV lukF-PV was PCR amplified using primers, forward 59-
CACCATGGCTCAACATATCACAC and reverse 59-GCTCA-
TAGGATTTTTTTCC. The resulting PCR product was then
TOPO cloned into pENTR/SD/D-TOPO (Invitrogen). This
plasmid was sequenced using M13 primers to confirm that the
insert was present in the correct orientation without mutations.
lukF-PV was subsequently cloned using an LR recombination
reaction into the expression vector pET-DEST42 (Invitrogen)
which introduced a C-terminal 6x-Histidine tag. This expression
clone was used to transform Rosetta2 E. coli (Novagen). Soluble
recombinant LukF-PV was produced by the Protein Production
Unit, Monash University by growth of the expression strain in
Auto Induction media at 28uC. The resulting recombinant LukF-
PV was purified by Nickel purification followed by gel filtration
and eluted in 100 mM NaP04, pH 7.4, 150 mM NaCl buffer.
Aliquots were frozen and stored at 280uC. The concentration of
recombinant LukF-PV was determined using the 2100 Bioanalyser
P230 kit (Agilent).
Quantification of LukF-PV Expression
Bacteria were grown in CCY media (3% yeast extract (Oxoid),
2% Bacto Casamino Acids (Difco), 2.3% sodium pyruvate (Sigma-
Aldrich), 0.63% Na2HPO4, 0.041% KH2PO4, pH 6.7). Overnight
cultures were diluted 1:100 into fresh media and then incubated at
37uC with shaking (180 rpm) until stationary phase (OD600 ,
1.8). Culture supernatants were harvested by centrifugation and
filter sterilized. The LukF-PV expression experiments were
performed in at least duplicate for each S. aureus strain.
Trichloroacetic acid was added to culture supernatants and
incubated at 4uC overnight. Precipitates were then harvested by
centrifugation, washed with acetone, air-dried and solubilized in a
sample buffer containing 1.7% SDS and 1% 2-mercaptoethanol.
The proteins were separated on 12% SDS-PAGE.
A peptide sequence specific to LukF-PV, HWIGNNYKDEN-
RATHT was synthesized and HRP conjugated polyclonal chicken
IgY raised against this peptide (Genscript). This antibody was used
to detect LukF-PV with enhanced chemiluminescence. Images
generated from the western blots were quantitated using GS800
Calibrated Densitometer and Quantity One (BioRad). 50 mg of
recombinant LukF-PV was used as an internal standard on each
gel, and was the positive control. Results observed with this
standard were set to 1.0. All other results were shown as a ratio
relative to this standard. RN4220 was used as a negative control.
Dru Typing
Sequence analysis of the mec-associated dru region was
performed as previously described [38]. A cluster analysis of dru
sequences was performed using the Polymorphic VNTR plug-in
tool of the BioNumerics software program (version 6.6; Applied
Maths, Ghent, Belgium). The analysis compares and aligns
sequences via an algorithm based on potential tandem dru repeat
duplications, substitutions, and indels (the DSI model) [29]. A
MST was generated from the similarity matrix with the root node
assigned to the sequence type with the greatest number of related
types. The default software parameters were used for analysis with
a bin distance of 1.0%. Thus, the distance between dru types of
99% to 100% similarity was 0, 98% to 99% similarity was assigned
a distance of 1, etc., on the MST. For cluster analysis, only dru
types separated by an MST distance of #1 (i.e., if they were
$98% similar) were considered closely related and assigned to the
same cluster.
Control Strain
The sequenced ST93-IVa [2B] strain JKD6159 (NCBI
GenBank Accession No. CP002114 and CP002115) was included
in this study for comparison [17].
Results
Susceptibility results, SCCmec typing together with a summary
of the resistance genes, spa types (using the Ridom Nomenclature)
and dru type are shown in Table 1. Further characterisations are as
follows:
Molecular Typing
By PFGE the 58 isolates (13 MSSA and 45 MRSA) had $80%
similarity with the sequenced JKD6159 strain (Figure 1). Eleven
pulsotypes were identified. The MSSA isolates consisted of three
pulsotypes, ‘‘A’’ – ‘‘C’’ with 12 of the 13 isolates grouped into two
closely related pulsotypes; ‘‘A’’ (9 isolates) and ‘‘C’’ (3 isolates). The
MRSA isolates consisted of eight pulsotypes (‘‘C’’ – ‘‘K’’) with 39
of the 45 isolates grouped into two closely related pulsotypes; ‘‘D’’
(36 isolates) and ‘‘J’’ (3 isolates). The MSSA pulsotypes ‘‘A’’ and
‘‘C’’ and the MRSA pulsotypes ‘‘D’’ and ‘‘J’’ were 92% related;
the difference presumably due to the insertion of the SCCmec type
IVa [2B] element into an existing restriction fragment in the two
MRSA pulsotypes. Single isolates of closely related MRSA
pulsotypes ‘‘I’’ (SAPWH71) and ‘‘K’’ (SAPWH53) lacked a
PVL-encoding phage. MRSA pulsotype ‘‘H’’ (20198) also lacked
a PVL-encoding phage, however unlike the other MRSA, carried
the SCCmec type V element with an additional ccr element
[5C2&5]. The remaining MSSA and three MRSA isolates were
classified into four unique pulsotypes (pulsotypes B, E, F, G).
Isolates representing each pulsotype were identified as ST93 by
MLST.
Seven spa types were identified with the majority of isolates
characterised as t202 (8/13 MSSA and 42/45 MRSA). The MST
algorithm clustered the spa types into two significantly different
Molecular Epidemiology of ST93 Community S aureus
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Figure 1. Dendrogram of the 58 pulsed-field gel electrophoresis patterns (PFGE) of ST93 (13 MSSA and 45 MRSA). Sequenced
JKD6159 strain was used as the ST93 control. S. aureus strain NCTC 8325 was used as the reference strain.
doi:10.1371/journal.pone.0043037.g001
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groups; t202, t4178, t5767; t1811, t4699; plus t6487; and t6485
(Figure 2).
DNA Microarray
The b-lactamase operon (blaZ, blaI, blaR) was detected in all
isolates (Table 1). Apart from isolate 20198, the MRSA carried
mecA as a part of the SCCmec type IVa [2B] element. Carriage of
other resistance genes was infrequent and variable. Five of the
MSSA were phenotypically erythromycin resistant and carried
ermC. Of the five erythromycin resistant MRSA isolates, three
carried ermC and one the staphylococcal msr(A) macrolide efflux
protein gene. A macrolide resistance gene was not detected in one
isolate that demonstrated phenotypic resistance (SAPWH39). Two
ermC harbouring MRSA isolates were not phenotypically erythro-
mycin resistant. A single MRSA isolate harboured the tetK
tetracycline resistant gene (isolated in Victoria in 2008), and two
MRSA isolates carried the quaternary ammonium compound
resistance protein C (qacC) gene (isolated in WA in 2009).
The 58 isolates were agr group III and capsule type 8. Although
the enterotoxin and tst1 genes were absent from all isolates, the
enterotoxin homologue ORF CM14 was present in 34 isolates
(4 MSSA and 30 MRSA) (Table S1). All isolates carried the hlb, hld
and hlIII hemolysin genes; the staphylokinase (sak), chemotaxis
inhibitory protein (chp) and staphylococcal complement inhibitor
(scn) genes; and the aur, splA, sspA, sspB, sspP protease genes.
Although the gene for a biofilm-associated protein, bap, was
absent, the biofilm operon icaACD was present in all isolates.
Most isolates carried the leukocidin lukX and lukY genes, the hl, hla
hemolysin genes and the splE protease genes.
The staphylococcal superantigen like or exotoxin-like genes (set
or ssl genes) and genes encoding MSCRAMMS (microbial surface
components recognizing adhesive matrix molecules) and the
immune evasion factors were homogeneous and characteristic
for ST93 (Tables S2, S3, S4 and S5).
Panton Valentine Leukocidin (PVL)
Apart from three MRSA isolates (SAPWH71, SAPWH53 and
20198) the lukS-PV/lukF-PV genes were detected in all isolates by
array hybridisation and PCR. All lukS-PV/lukF-PV positive isolates
carried the PVL-encoding phage WSa2USA. Using the proposed
progenitor PVL gene in WSLT/ST30 as a reference sequence, all
isolates were similar, having the same R variant SNP profile with
three substitutions compared to WSLT. This SNP profile is
associated with the WSa2USA phage.
lukF-PV expression is shown in Figure 3 and was measured to
determine if there was a consistent expression profile across
different ST93 strains. As expected, ST93 isolates which did not
contain lukS-PV/lukF-PV did not express LukF-PV. However, there
Figure 2. Minimum spanning tree (MST) of the seven ST93 spa types. Cluster analysis was performed using the spa typing plug-in tool of the
BioNumerics program. spa types separated by an MST distance of #1 (i.e., if they were $98% similar) were considered closely related and assigned to
the same cluster. MSSA and MRSA spa types are designated in red and green print respectively. Pulsed-field gel electrophoresis (PFGE) pulsotypes
and dru types (dt) are recorded for each spa type.
doi:10.1371/journal.pone.0043037.g002
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were three isolates (SAPCRGH95 isolated in NSW, SAPAH21
isolated in Vic, and 15587 isolated in WA) which were PVL
positive by array hybridization and PCR but did not express
LukF-PV indicating that there may be regulatory differences such
as an agr defect in these isolates to account for the absence of
LukF-PV. All other isolates produced LukF-PV, with expression
levels similar between most strains.
dru Typing
Six dru types were identified (Table 1). The majority of isolates
(35/45) were dt10 (33 dt10a, 1 dt10 g and 1 dt10i). The remaining
nine SCCmec type IVa [2B] isolates were dru type dt4d (three
isolates) and dt3b (6 isolates). The SCCmec type V [5C2&5] isolate
(20198) was dt11i. The MST algorithm clustered the six dru types
into three significantly different groups; dt10, dt4d plus dt3b, and
dt11 (Figure 4). This suggests the SCCmec element may have been
acquired on at least three occasions by ST93.
Discussion
CA-MRSA is thought to emerge when a locally prevalent strain
of methicillin susceptible S. aureus (MSSA) acquires a SCCmec
element and utilizes mobile genetic elements and single nucleotide
polymorphisms to establish local and geographic niches [39].
Although the vertical and horizontal transmission of SCCmec
elements into S. aureus has occurred on multiple occasions in the
Australian community only a small number of clones have
successfully found an ecological niche to predominate over other
CA-MRSA clones [40]. PVL-positive ST93-IV [2B] is one such
clone, and since 2000 has been reported across Australia and is
responsible for the increasing prevalence of CA-MRSA infections
nationwide [13].
Conflicting hypotheses have been proposed to explain the
molecular evolution of ST93-MRSA. In 2008 Munckhof and
colleagues found little genetic diversity within ST93-IV [2B]
suggesting it arose from one PVL-positive binary subtype of ST93
MSSA after the acquisition of SCCmec [41]. However in 2009
Tong and colleagues identified multiple spa types in ST93-MRSA
and ST93-MSSA and proposed their data supported an early
acquisition of SCCmec with subsequent rearrangement of the spa
sequence or multiple independent acquisitions of SCCmec and
coexistence of MSSA and MRSA versions of the same lineage
[42]. Although seven spa types were described in this study, cluster
analysis of the seven spa sequences using the Spa typing plug-in
tool of the BioNumerics software program shows six of the spa
types are closely related and can be assigned to a single cluster
(data not shown).
Unlike the Tong study, which examined the spa types of
geographically localized ST93 S aureus collected over a short
period, the current study examined ST93 S aureus isolated across
Australia over sixteen years using a variety of molecular tools,
providing greater power to detect unique evolutionary events in
geographically diverse regions.
Prior to the isolation of ST93-IV [2B], S aureus surveillance
screening of aboriginal people living in 11 remote Western
Australian communities identified ST93 as the most prevalent
MSSA lineage [20]. Although located in three geographically
distant regions of WA, the ST93-MSSA examined from these
communities, (W17S isolated in 1995, Y113S in 1996 and C229T
and N126W in 2003, and) exhibit limited diversity within their
PFGE patterns, spa types and microarray DNA profiles. Their two
spa types, t202 [3 isolates (‘‘PFGE C’’)] and t5767 (‘‘PFGE A’’) are
closely related and are assigned to the same cluster. The
microarray DNA profiles for the two ST93-MSSA isolated in
the Northern Territory in 1992 (WBG7735 and WBG7762) are
homogeneous with the four WA remote community ST-93 MSSA.
In addition their PFGE patterns are either identical (‘‘PFGE A’’)
or 90% related (‘‘PFGE B’’), and their spa types, t4699 and t4178,
Figure 3. Relative LukF-PV expression in ST93 isolates. All isolates were tested for LukF-PV expression using western blot and LukF-PV specific
antibody. Results are expressed as optical density of test strain relative to a 50 mg control of rLukF-PV that was run on every gel. All experiments were
performed with multiple replicates and mean and range is shown. Positive control, rLUKF-PV; negative control, RN4220.
doi:10.1371/journal.pone.0043037.g003
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are assigned to the same cluster. The DNA microarray profiles for
the five ST93-MSSA, (9506160A, 9509712N, 9524093R,
9525206A and 9529120L) isolated in the state’s capital, Perth in
2008 (located 700–2000 km from the remote communities and
over 3,000 km from the Northern Territory border) are also
homogeneous with the Western Australian remote community
strains. The PFGE pattern for these isolates is ‘‘PFGE A’’. The spa
types for four of these strains are t202 (3 isolates) and t5767. The
spa type for 9509712N (t6485) cannot be assigned to the same
cluster. The PFGE patterns, spa types and microarray DNA
profiles for the MSSA isolated on the Australian eastern seaboard
(UQ40– Queensland in 2008 and DP2039– Victoria in 2007) are
identical to three Perth ST93-MSSA-t202 isolates.
As shown in Figure 1 the MRSA isolates are $80% related by
PFGE with the majority of isolates falling into pulsotype D. Similar
to the MSSA pulsotypes, pulsotype D was dispersed throughout
Australia over the eight years. Although rearrangement of the spa
sequence has occurred several times, the PFGE patterns and
microarray DNA profiles of the 13 ST-93 MSSA isolates suggests
the ST93 core and accessory genome is very stable. All carry the
PVL-encoding phage WSa2USA and their lukS-PV/lukF-PV genes
have the same R variant SNP profile. The isolates produce similar
expression levels of LukF-PV with no apparent relationship
between subtype and PVL expression. The emergence of five
different spa types, albeit four types assigned to the same cluster,
suggests ST93-MSSA emerged some time ago from a common spa
type. As the spa sequences are similar it is not possible to predict
the ancestral strain; however one strain, ST93-MSSA-t202,
predominates and has successfully disseminated across Australia.
Like ST93-MSSA, ST93-MRSA has multiple spa types;
including the closely related t202 and t4178, identified in ST93-
MSSA, t1811 and t6487, all of which are assigned to the same
cluster. t202 has the largest number of isolates; 42 of the 45 ST93-
MRSA. SCCmec and dru typing indicates the SCCmec element has
been acquired by ST93-MRSA-t202 on at least three occasions;
dt10 (SCCmec type IVa [2B]), dt3b/dt4d (SCCmec type IVa [2B])
and dt11i (SCCmec type V [5C&5]). Unlike ST93-IVa [2B]-t202,
ST93-V [5C&5]-t202 does not carry the lukS-PV/lukF-PV genes.
The PVL-negative ST93-IVa [2B]-t1811 isolate may have arisen
by independent acquisition of SCCmec IVa [2B] or by the
subsequent rearrangement of the spa sequence.
As for ST93-MSSA, the PFGE patterns and microarray DNA
profiles of the 45 ST-93 MRSA isolates suggests the ST93 core
and accessory genome is stable. Forty three of the 45 isolates carry
the PVL-encoding phage WSa2USA. The lukS-PV/lukF-PV genes
have the same R variant SNP profile and produce similar
expression levels of LukF-PV as reported in ST93-MSSA.
Apart from the ermC gene which was identified in several early
ST93-MSSA and ST93-MRSA isolates, ST93 S. aureus initially
carried few antibiotic resistance elements. However since 2008, in
addition to mecA and ermC, some isolates of ST93-MRSA have
acquired the msr(A) and tetK resistance genes. Although the dfrA
gene was not detected by the microarray DNA, SAPWH53 is
phenotypically trimethoprim resistant (presumably due to an
alternative trimethoprim resistance gene or a different dfrA allele).
In addition, the quaternary ammonium compound resistance
protein C gene qacC is carried by two isolates. The acquisition of
several resistance genes by an epidemic PVL-positive CA-MRSA
clone is not unique to ST93-IV [2B]. The USA300 clone (ST8-IV
[2B]), initially resistant only to semi-synthetic penicillins and
macrolides, is now, frequently resistant to other antimicrobial
agents including clindamycin, tetracycline, mupirocin, and the
fluoroquinolones; occasionally resistant to gentamicin and tri-
methoprim-sulfamethoxazole, and may have reduced susceptibil-
ity to daptomycin [43].
Single strain outbreaks of ST93-IV [2B] have not been reported
in Australian hospitals, however as has been reported in United
States hospitals with USA300 [44], ST93-IV [2B] has become a
Figure 4. Minimum spanning tree (MST) of the six ST93 dru types. Cluster analysis was performed using the Polymorphic VNTR plug-in tool
of the BioNumerics program. dru types separated by an MST distance of #1 (i.e., if they were $98% similar) were considered closely related and
assigned to the same cluster. Pulsed-field gel electrophoresis (PFGE) pulsotypes and spa types are recorded for each dru type.
doi:10.1371/journal.pone.0043037.g004
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major cause of healthcare-associated/onset infection. In 2008
Munckhof and colleagues reported nearly three quarters of
nmMRSA infections in their hospital-based study were healthcare
associated, of which ST93-IV [2B] predominated [41].
Conclusion
This study has demonstrated that although multiple rearrange-
ments of the spa sequence have occurred, the core genome in
ST93 S. aureus is very stable. Since 2008 PVL-positive ST93-
MSSA-t202 has become the predominant ST93-MSSA across
Australia. We have shown the emergence of ST93-MRSA has
been due to independent acquisitions of different dru-defined type
IV and type V SCCmec elements in several spa-defined ST93-
MSSA backgrounds. Rearrangement of the spa sequence in ST93-
MRSA has subsequently occurred in some of these strains.
Although several ST93-MRSA strains have been identified in this
study, little genetic diversity was identified for most MRSA
isolates, with PVL-positive ST93-IVa [2B]-t202-dt10 predominant
across Australia. However to determine if ST93-IVa [2B] t202-
dt10 has arisen from one PVL-positive ST93-MSSA-t202, or by
independent acquisitions of SCCmec-IVa [2B]-dt10 into multiple
PVL-positive ST93-MSSA-t202 strains will require whole genomic
sequencing of the isolates. Furthermore, comparative genomic
sequencing may further enhance our understanding of the
molecular basis for the emergence and increased virulence of
ST93 CA-MRSA. At a time when this clone is acquiring
additional resistance genes and an increased potential for
infections in the healthcare setting, understanding the means for
SCCmec acquisition, virulence determinants and transmission
dynamics is crucial if we are to prevent this clone from becoming
established in hospitals.
Supporting Information
Table S1 Microarray DNA ST93 virulence profile
(DOCX)
Table S2 Microarray DNA ST93 ST93 staphylococcal
superantigen/enterotoxin-like genes (set/ssl) profile.
(DOCX)
Table S3 and S4 Microarray DNA ST93 ST93
MSCRAMMs and adhesion profile.
(DOCX)




We gratefully acknowledge the following: Julie Pearson, Hui-leen Tan,
Lynne Wilson, Yi-Kong Chew, Denise Daley, Tam Le and Ka Yan Wong
from the Australian Collaborating Centre for Enterococcus and Staphylococcus
Species (ACCESS) Typing and Research for their technical assistance; the
WA Genome Resource Centre, Department of Clinical Immunology and
Biochemical Genetics, Royal Perth Hospital for sequencing; the Molecular
Biology Laboratory at Royal Perth Hospital for MLST; and the public and
private medical laboratories in Western Australia and the Australian
Group for Antimicrobial Resistance (AGAR) for referring the isolates.
Author Contributions
Conceived and designed the experiments: GWC FGO KJC. Performed the
experiments: GWC KYC. Analyzed the data: GWC KYC SM RVG BPH
FGO KJC. Contributed reagents/materials/analysis tools: GWC KYC
SM RVG BPH TPS RE FGO KJC. Wrote the paper: GWC KYC BPH.
References
1. Tenover FC, McDougal LK, Goering RV, Killgore G, Projan SJ, et al. (2006)
Characterization of a strain of community-associated methicillin-resistant
Staphylococcus aureus widely disseminated in the United States. J Clin
Microbiol 44: 108–118.
2. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, et al.
(2003) Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococ-
cus aureus isolates from the United States: establishing a national database. J Clin
Microbiol 41: 5113–5120.
3. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, et al. (2003)
Community-acquired methicillin-resistant Staphylococcus aureus carrying
Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9:
978–984.
4. Bekkhoucha SN, Cady A, Gautier P, Itim F, Donnio PY (2009) A portrait of
Staphylococcus aureus from the other side of the Mediterranean Sea: molecular
characteristics of isolates from Western Algeria. Eur J Clin Microbiol Infect Dis
28: 553–555.
5. Udo EE, O’Brien FG, Al-Sweih N, Noronha B, Matthew B, et al. (2008) Genetic
lineages of community-associated methicillin-resistant Staphylococcus aureus in
Kuwait hospitals. J Clin Microbiol 46: 3514–3516.
6. Boyle-Vavra S, Ereshefsky B, Wang CC, Daum RS (2005) Successful
multiresistant community-associated methicillin-resistant Staphylococcus aureus
lineage from Taipei, Taiwan, that carries either the novel Staphylococcal
chromosome cassette mec (SCCmec) type VT or SCCmec type IV. J Clin
Microbiol 43: 4719–4730.
7. Collignon P, Gosbell I, Vickery A, Nimmo G, Stylianopoulos T, et al. (1998)
Community-acquired meticillin-resistant Staphylococcus aureus in Australia.
Australian Group on Antimicrobial Resistance. Lancet 352: 145–146.
8. Riley D, MacCulloch D, Morris AJ (1998) Methicillin-resistant S. aureus in the
suburbs. N Z Med J 111: 59.
9. Ellington MJ, Ganner M, Warner M, Cookson BD, Kearns AM (2010)
Polyclonal multiply antibiotic-resistant methicillin-resistant Staphylococcus
aureus with Panton-Valentine leucocidin in England. J Antimicrob Chemother
65: 46–50.
10. Nimmo GR, Coombs GW (2008) Community-associated methicillin-resistant
Staphylococcus aureus (MRSA) in Australia. Int J Antimicrob Agents 31: 401–
410.
11. Tristan A, Bes M, Meugnier H, Lina G, Bozdogan B, et al. (2007) Global
distribution of Panton-Valentine leukocidin–positive methicillin-resistant Staph-
ylococcus aureus, 2006. Emerg Infect Dis 13: 594–600.
12. Munckhof WJ, Schooneveldt J, Coombs GW, Hoare J, Nimmo GR (2003)
Emergence of community-acquired methicillin-resistant Staphylococcus aureus
(MRSA) infection in Queensland, Australia. Int J Infect Dis 7: 259–264.
13. Coombs GW, Nimmo GR, Pearson JC, Christiansen KJ, Bell JM, et al. (2009)
Prevalence of MRSA strains among Staphylococcus aureus isolated from
outpatients, 2006. Commun Dis Intell 33: 10–20.
14. Peleg AY, Munckhof WJ, Kleinschmidt SL, Stephens AJ, Huygens F (2005) Life-
threatening community-acquired methicillin-resistant Staphylococcus aureus
infection in Australia. Eur J Clin Microbiol Infect Dis 24: 384–387.
15. Risson DC, O’Connor ED, Guard RW, Schooneveldt JM, Nimmo GR (2007) A
fatal case of necrotising pneumonia due to community-associated methicillin-
resistant Staphylococcus aureus. Med J Aust 186: 479–480.
16. Chua K, Seemann T, Harrison PF, Davies JK, Coutts SJ, et al. (2010) Complete
genome sequence of Staphylococcus aureus strain JKD6159, a unique
Australian clone of ST93-IV community methicillin-resistant Staphylococcus
aureus. J Bacteriol 192: 5556–5557.
17. Chua KY, Seemann T, Harrison PF, Monagle S, Korman TM, et al. (2011) The
dominant Australian community-acquired methicillin-resistant Staphylococcus
aureus clone ST93-IV [2B] is highly virulent and genetically distinct. PLoS One
6: e25887.
18. Ellington MJ, Ganner M, Warner M, Boakes E, Cookson BD, et al. (2010) First
international spread and dissemination of the virulent Queensland community-
associated methicillin-resistant Staphylococcus aureus strain. Clin Microbiol
Infect 16: 1009–1012.
19. Coombs GW, Pearson JC, O’Brien FG, Murray RJ, Grubb WB, et al. (2006)
Methicillin-resistant Staphylococcus aureus clones, Western Australia. Emerg
Infect Dis 12: 241–247.
20. O’Brien FG, Coombs GW, Pearman JW, Gracey M, Moss F, et al. (2009)
Population dynamics of methicillin-susceptible and -resistant Staphylococcus
aureus in remote communities. J Antimicrob Chemother 64: 684–693.
21. Costa AM, Kay I, Palladino S (2005) Rapid detection of mecA and nuc genes in
staphylococci by real-time multiplex polymerase chain reaction. Diagn
Microbiol Infect Dis 51: 13–17.
22. CLSI (2009) Performance standards for antimicrobial disk susceptibility tests. 7th
ed Approved standard M02-A10. CLSI, Wayne, PA.
23. CLSI (2009) Performance standards for antimicrobial susceptibility testing. 19th
informational supplement M100-S18. CLSI, Wayne, PA.
24. CA-SFM (1996) Report of the Comité de l’Antibiogramme de la Société
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